Sexual Enhancement Supplement Recalled Over Undeclared Prescription Drugs

Best Supplements Best Prices has initiated a voluntary nationwide recall of WAP Sensual Enhancement Capsules after the FDA identified undeclared prescription drugs in the product. According to the FDA announcement, the capsules contained sildenafil (Viagra's active ingredient), tadalafil (Cialis's active ingredient), and flibanserin (Addyi's active ingredient)—all at or near prescription strength and without label disclosure. The undeclared drugs pose serious cardiovascular and drug-interaction risks, particularly for consumers taking blood pressure medications or cardiac treatments. The company advised consumers to stop using the product immediately and return it to the retailer for a refund.

What Happened

The FDA identified multiple lots of WAP Sensual Enhancement Capsules as adulterated products containing three Class IV prescription medications without disclosure. FOX 35 Orlando reported that the product was marketed as a dietary supplement for sexual enhancement but functionally operated as an unapproved drug product due to the presence of pharmaceutical-grade active ingredients. The FDA's detection triggered a voluntary recall of all affected lot numbers, with the manufacturer instructing consumers who had purchased the product to discontinue use immediately and return it to the point of purchase.

What the Source Says

The FDA's laboratory analysis confirmed the presence of sildenafil (typical therapeutic range: 25–100 mg), tadalafil (typical therapeutic range: 5–20 mg), and flibanserin (typical therapeutic dose: 100 mg daily) in the supplement capsules. These were not trace contaminants but active pharmaceutical ingredients present at prescription strength. Sildenafil and tadalafil are phosphodiesterase-5 (PDE5) inhibitors indicated for erectile dysfunction and pulmonary hypertension; they carry black-box warnings when combined with nitrate medications used for angina and can cause dangerous blood pressure drops. Flibanserin is an FDA-approved medication for hypoactive sexual desire disorder in women, requiring physician supervision due to risks of dizziness, fainting, and interactions with alcohol and other drugs. The simultaneous presence of all three substances in a single capsule—without dose transparency, quality control documentation, or medical oversight—creates an exceptionally hazardous product.

Beyond the Headline

This recall is not an isolated incident. The dietary supplement industry, valued at over $150 billion globally in 2023, operates under lighter pre-market scrutiny than pharmaceuticals under the Dietary Supplement Health and Education Act (DSHEA), making it vulnerable to adulteration. While manufacturers are theoretically responsible for safety, enforcement relies primarily on post-market surveillance and consumer complaints. Sexual enhancement supplements have been a particular target for adulteration; dietary supplements face different regulatory oversight than drugs, which enables some operators to exploit the gap. The FDA and international regulators have documented dozens of similar cases over the past decade, with undeclared sildenafil appearing in roughly 80% of seized counterfeit sexual-enhancement products. Best Supplements Best Prices' voluntary recall demonstrates appropriate response, but it also reflects the reality that adulterated products routinely reach retail shelves—both online and in physical stores—before detection occurs. The case highlights a systemic vulnerability: many consumers purchase supplements from third-party retailers or online marketplaces without verifying the manufacturer's legitimacy or checking the FDA's recall database.

What This Means for Consumers

If you purchased WAP Sensual Enhancement Capsules: Stop use immediately and do not consume any remaining inventory. Return the product to the retailer where it was purchased for a full refund. Search the FDA's recall database by brand name and lot number to confirm your purchase.

If you took this supplement and take blood-pressure medications, nitrates, antidepressants, or blood-thinners: Contact your healthcare provider or pharmacist to discuss potential drug interactions. Your doctor may recommend blood-pressure checks or an EKG to monitor for adverse effects. Do not delay if you experienced chest pain, severe headache, fainting, or unusual dizziness after using this product.

For sexual function concerns: Consult a physician, urologist, or nurse practitioner rather than relying on unverified dietary supplements. Prescription medications like sildenafil and tadalafil have established dosing protocols, contraindication screening, and adverse-event monitoring when prescribed by a licensed provider. This approach is safer than consuming supplements with unknown ingredient strength.

When evaluating any sexual enhancement supplement: Verify the manufacturer's transparency regarding third-party testing—look for NSF Certified for Sport, USP Verified, or ConsumerLab certification seals on the label. Check the FDA website for active recalls before purchase. Purchase only from established retailers with clear return policies and verifiable contact information. Understand that dietary supplements are regulated differently from drugs, meaning label claims face less stringent pre-approval scrutiny.

What to Watch Next

Monitor the FDA's Office of Criminal Investigations announcements for potential enforcement action against Best Supplements Best Prices or affiliated distributors. The agency may pursue civil or criminal penalties if evidence demonstrates knowing or negligent distribution of adulterated products. Additional lot numbers or related product lines under the same brand may be identified as FDA testing continues; check the agency's recall page weekly if you purchased from this manufacturer. The recall may also trigger a broader regulatory review of sexual-enhancement supplement suppliers; expect potential follow-on recalls or warning letters to retailers stocking similar products. Consumer reports of adverse events—chest pain, severe headache, syncope, or drug-interaction symptoms—tied to this product will be logged in the FDA's MedWatch database and may influence future enforcement prioritization. Watch for retail responses regarding supplier vetting and shelf-space decisions for sexual-enhancement supplement categories.